US3065142A
(en)
|
1958-07-30 |
1962-11-20 |
Armour Pharma |
Gastric resistant medicinal preparation
|
US4006227A
(en)
|
1973-11-15 |
1977-02-01 |
Gallegos Alfred J |
Compositions and methods for fertility control
|
US4024240A
(en)
|
1975-07-18 |
1977-05-17 |
Eli Lilly And Company |
Antibiotic A-32390 compositions
|
US4343804A
(en)
|
1979-03-26 |
1982-08-10 |
A. H. Robins Company, Inc. |
4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
|
NZ196700A
(en)
|
1980-04-18 |
1983-04-12 |
Smith & Nephew Ass |
Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives
|
DE3269604D1
(en)
|
1981-06-26 |
1986-04-10 |
Schering Corp |
Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
|
US4464372A
(en)
|
1982-08-16 |
1984-08-07 |
Schering Corporation |
Imidazo[1,2-b]pyridazines
|
GB8305245D0
(en)
|
1983-02-25 |
1983-03-30 |
Fujisawa Pharmaceutical Co |
Imidazo-heterocyclic compounds
|
GB8307865D0
(en)
|
1983-03-22 |
1983-04-27 |
Fujisawa Pharmaceutical Co |
Benzimidazole derivatives
|
GB8415540D0
(en)
|
1984-06-18 |
1984-07-25 |
Fujisawa Pharmaceutical Co |
Imidazoisoquinoline compounds
|
US4725601A
(en)
|
1985-06-04 |
1988-02-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
|
JPS625966A
(ja)
|
1985-07-03 |
1987-01-12 |
Nippon Shinyaku Co Ltd |
ベンズイミダゾ−ル誘導体
|
EP0228006A1
(de)
|
1985-12-16 |
1987-07-08 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazopyridinverbindungen und Verfahren zu ihrer Herstellung
|
US4753945A
(en)
|
1986-02-19 |
1988-06-28 |
Eye Research Institute Of Retina Foundation |
Stimulation of tear secretion with phosphodiesterase inhibitors
|
US5286494A
(en)
|
1986-07-02 |
1994-02-15 |
Schering Aktiengesellschaft |
Medicinal agents with sustained action
|
GB8621425D0
(en)
|
1986-09-05 |
1986-10-15 |
Smith Kline French Lab |
Compounds
|
US4833149A
(en)
|
1986-09-22 |
1989-05-23 |
Ortho Pharmaceutical Corporation |
2- or 3-aryl substituted imidazo[1,2-a]pyridines
|
US4791117A
(en)
|
1986-09-22 |
1988-12-13 |
Ortho Pharmaceutical Corporation |
2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
|
EP0264883A3
(de)
|
1986-10-21 |
1990-04-04 |
Banyu Pharmaceutical Co., Ltd. |
Substituierte Pyridinderivate
|
US4831041A
(en)
|
1986-11-26 |
1989-05-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazopyridine compounds and processes for preparation thereof
|
JP2656101B2
(ja)
|
1987-07-16 |
1997-09-24 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
新規ジアゾール
|
GB8717644D0
(en)
|
1987-07-24 |
1987-09-03 |
Smithkline Beckman Intercredit |
Compounds
|
GB8722488D0
(en)
|
1987-09-24 |
1987-10-28 |
Fujisawa Pharmaceutical Co |
Imidazopyridine compound
|
GB8804444D0
(en)
|
1988-02-25 |
1988-03-23 |
Smithkline Beckman Intercredit |
Compounds
|
US4900775A
(en)
|
1988-02-29 |
1990-02-13 |
Gaf Chemicals Corporation |
Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone
|
US5011843A
(en)
|
1988-05-31 |
1991-04-30 |
Iolab Corporation |
Treatment of glaucoma using phosphodiesterase inhibitors
|
CA2011086A1
(en)
|
1989-03-17 |
1990-09-17 |
Karl-Heinz Geiss |
2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
|
GB8908229D0
(en)
|
1989-04-12 |
1989-05-24 |
Smithkline Beckman Intercredit |
Compounds
|
DE3917232A1
(de)
|
1989-05-26 |
1990-11-29 |
Basf Ag |
4-arylmethamino-2,3-dialkyl-chinoline, ihre verwendung und daraus hergestellte arzneimittel
|
DE3917233A1
(de)
|
1989-05-26 |
1990-11-29 |
Basf Ag |
8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
|
DE3943385A1
(de)
|
1989-12-27 |
1991-07-04 |
Schering Ag |
Mittel zur transdermalen applikation enthaltend rolipram
|
FR2657257B1
(fr)
|
1990-01-19 |
1994-09-02 |
Rhone Poulenc Sante |
Procede de preparation de medicaments sous forme de perles.
|
WO1991014677A1
(fr)
|
1990-03-28 |
1991-10-03 |
Otsuka Pharmaceutical Co., Ltd. |
Derive de quinoline, medicament anti-ulcereux contenant ce derive et production de ce derive
|
US5041442A
(en)
|
1990-07-31 |
1991-08-20 |
Syntex (U.S.A.) Inc. |
Pyrrolo(1,2-a)pyrazines as inhibitors of gastric acid secretion
|
US5698711A
(en)
|
1991-01-28 |
1997-12-16 |
Rhone-Poulenc Rorer Limited |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group
|
SE9100920D0
(sv)
|
1991-03-27 |
1991-03-27 |
Astra Ab |
New active compounds
|
EP0587744B1
(de)
|
1991-05-28 |
2003-07-16 |
McNEIL-PPC, Inc. |
Kaubare zusammensetzung zur arzneimittelfreisetzung
|
JP3108483B2
(ja)
|
1991-09-30 |
2000-11-13 |
日清製粉株式会社 |
インドール誘導体およびこれを有効成分とする抗潰瘍薬
|
JP3038064B2
(ja)
|
1991-10-07 |
2000-05-08 |
日清製粉株式会社 |
インドール誘導体およびこれを有効成分とする抗潰瘍薬
|
EP0609328B1
(de)
|
1991-10-25 |
1999-04-28 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Pyrrolo-pyridazine mit magen- und darmschutzwirkungen
|
US5262171A
(en)
|
1991-11-25 |
1993-11-16 |
Isp Investments Inc. |
Pharmaceutical tablet with PVP having enhanced drug dissolution rate
|
JP3722293B2
(ja)
|
1991-12-18 |
2005-11-30 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
新規な薬学的固体分散物
|
GB9201693D0
(en)
|
1992-01-27 |
1992-03-11 |
Smithkline Beecham Intercredit |
Compounds
|
WO1993025517A1
(en)
*
|
1992-06-15 |
1993-12-23 |
Celltech Limited |
Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
|
GB9212693D0
(en)
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
IL106517A0
(en)
|
1992-07-28 |
1994-08-26 |
Rhone Poulenc Rorer Ltd |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic or heteroatom containing linking group
|
US5891904A
(en)
|
1992-09-14 |
1999-04-06 |
Wolf-Georg Forssmann |
Use of inhibitors of phosphodiesterase IV
|
JP3284622B2
(ja)
|
1992-10-23 |
2002-05-20 |
ソニー株式会社 |
ディスク装置
|
US5429824A
(en)
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
KR0144833B1
(ko)
|
1992-12-28 |
1998-07-15 |
김태훈 |
신규의 퀴나졸린 유도체 및 그의 제조방법
|
IL108520A
(en)
|
1993-02-15 |
1997-09-30 |
Byk Gulden Lomberg Chem Fab |
2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
DE59409983D1
(de)
|
1993-04-22 |
2002-01-10 |
Byk Gulden Lomberg Chem Fab |
Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien
|
ES2176252T3
(es)
|
1993-07-02 |
2002-12-01 |
Altana Pharma Ag |
Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos.
|
JP3284686B2
(ja)
|
1993-08-30 |
2002-05-20 |
株式会社明電舎 |
ブレーキダイナモメータシステムのブレーキトルク制御方式
|
UA48122C2
(uk)
|
1993-10-11 |
2002-08-15 |
Бік Гульден Ломберг Хеміше Фабрік Гмбх |
АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
|
DE59510131D1
(de)
|
1994-07-28 |
2002-05-02 |
Byk Gulden Lomberg Chem Fab |
Imidazopyridin-azolidinone
|
JP3031280B2
(ja)
|
1994-08-19 |
2000-04-10 |
東陶機器株式会社 |
便器洗浄装置
|
GB9514473D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Chemical compounds
|
SE512835C2
(sv)
|
1996-01-08 |
2000-05-22 |
Astrazeneca Ab |
Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
|
US6114537A
(en)
|
1996-02-26 |
2000-09-05 |
Apotex Inc. |
Process for scavenging thiols
|
US5677302A
(en)
|
1996-02-26 |
1997-10-14 |
Apotex Inc. |
Thiadiazole compounds useful as proton pump inhibitors
|
FR2746800B1
(fr)
|
1996-03-29 |
1998-06-05 |
Jouveinal Inst Rech |
Diazepino-indoles inhibiteurs de phosphodiesterases 4
|
US5972381A
(en)
|
1996-06-28 |
1999-10-26 |
Schering Corporation |
Solid solution of an antifungal agent with enhanced bioavailability
|
US5762953A
(en)
|
1996-08-22 |
1998-06-09 |
Theratech, Inc. |
Transdermal propentofylline compositions for the treatment of Alzheimers disease
|
BR9807399B1
(pt)
|
1997-02-17 |
2011-04-19 |
|
composição para o tratamento de sìndrome da angústia respiratória infantil (irds) ou sìndrome da angústia respiratória aguda (ards) compreendendo 3-(ciclopropilmetóxi)-n-(3,5-dicloro-4-piridinil)-4-(difl uorometóxi) benzamida e tensoativo do pulmão, e seu uso.
|
SE9700661D0
(sv)
|
1997-02-25 |
1997-02-25 |
Astra Ab |
New compounds
|
US6624181B1
(en)
|
1997-02-28 |
2003-09-23 |
Altana Pharma Ag |
Synergistic combination
|
CN101255164A
(zh)
|
1997-05-28 |
2008-09-03 |
奥坦纳医药公司 |
稠合的二氢吡喃类化合物及其用途
|
IT1294748B1
(it)
|
1997-09-17 |
1999-04-12 |
Permatec Tech Ag |
Formulazione per un dispositivo transdermico
|
IL136249A0
(en)
|
1997-12-08 |
2001-05-20 |
Byk Gulden Lomberg Chem Fab |
Suppository containing an acid-labile active compound
|
SE9801526D0
(sv)
|
1998-04-29 |
1998-04-29 |
Astra Ab |
New compounds
|
WO1999056776A2
(en)
|
1998-05-07 |
1999-11-11 |
Corixa Corporation |
Adjuvant composition and methods for its use
|
EP1085846A2
(de)
|
1998-06-08 |
2001-03-28 |
Advanced Medicine, Inc. |
Mehrfachbindende inhibitoren des microsomalen triglyceridtransferase-proteins
|
SE9802793D0
(sv)
|
1998-08-21 |
1998-08-21 |
Astra Ab |
New compounds
|
SE9802794D0
(sv)
|
1998-08-21 |
1998-08-21 |
Astra Ab |
New compounds
|
WO2000012078A1
(en)
|
1998-08-26 |
2000-03-09 |
Smithkline Beecham Corporation |
Therapies for treating pulmonary diseases
|
TR200100805T2
(tr)
|
1998-09-23 |
2001-08-21 |
Byk Gulden Lomberg Chemische Fabr�K Gmbh |
Tetrahidropiridoeterler
|
HUP0103947A3
(en)
|
1998-09-29 |
2002-06-28 |
Fujisawa Pharmaceutical Co |
Novel methanesulfonate salts of pyridopyrazine compound and crystals thereof and their pharmaceutical use
|
EP1120120A4
(de)
|
1998-10-05 |
2009-04-29 |
Eisai R&D Man Co Ltd |
Tableten die sich unmittelbar in der mundhöhle auflösen
|
US20020006418A1
(en)
|
1998-10-13 |
2002-01-17 |
John Kung |
Composition to enhance permeation of topical skin agents
|
DE69938192D1
(en)
|
1998-11-03 |
2008-04-03 |
Nycomed Gmbh |
Imidazonaphthyridine
|
US6417190B1
(en)
|
1998-12-17 |
2002-07-09 |
Boehringer Ingelheim Pharma Kg |
Tricyclic nitrogen heterocycles as PDE IV inhibitors
|
DZ3019A1
(fr)
|
1999-03-01 |
2005-05-20 |
Smithkline Beecham Corp |
Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
|
US6270807B1
(en)
|
1999-03-02 |
2001-08-07 |
L. Perrigo Company |
Taste-masked pharmaceutical composition
|
CA2364258C
(en)
|
1999-03-10 |
2008-12-30 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis
|
CN1126468C
(zh)
|
1999-04-08 |
2003-11-05 |
王力田 |
一种黑玉米秸秆饮料及其制备方法
|
ATE240956T1
(de)
|
1999-04-17 |
2003-06-15 |
Altana Pharma Ag |
Haloalkoxy-imidazonaphthyridine
|
KR100328972B1
(ko)
|
1999-04-23 |
2002-03-20 |
서경배 |
피부 유용 활성성분을 함유한 화장료 또는 피부도포용 의약품 조성물의 제조방법 및 이러한 방법에 의해 제조된 화장료 또는 피부도포용 의약품 조성물
|
CA2372850C
(en)
|
1999-05-04 |
2011-01-18 |
Ulrich Kilian |
Synergistic combination comprising roflumilast and a pde-3 inhibitor
|
DE19925710C2
(de)
|
1999-06-07 |
2002-10-10 |
Byk Gulden Lomberg Chem Fab |
Neue Zubereitung und Darreichungsform enthaltend einen säurelabilen Protonenpumpenhemmer
|
EA005803B1
(ru)
|
1999-06-07 |
2005-06-30 |
Алтана Фарма Аг |
Новый препарат и форма для введения, включающие неустойчивое в кислой среде действующее вещество
|
ES2310166T3
(es)
|
1999-08-03 |
2009-01-01 |
Lilly Icos Llc |
Composicion farmaceutica que contiene tadalafil.
|
ATE320800T1
(de)
|
1999-08-21 |
2006-04-15 |
Altana Pharma Ag |
Synergistische kombination von roflumilast und salmeterol
|
US6174878B1
(en)
|
1999-08-31 |
2001-01-16 |
Alcon Laboratories, Inc. |
Topical use of kappa opioid agonists to treat otic pain
|
US6375968B1
(en)
|
1999-10-22 |
2002-04-23 |
3M Innovative Properties Company |
Encapsulated active material immobilized in hydrogel microbeads
|
KR100729836B1
(ko)
|
1999-10-25 |
2007-06-18 |
소니 가부시끼 가이샤 |
콘텐츠 데이터 관리방법
|
NZ518002A
(en)
|
1999-10-29 |
2004-01-30 |
Smithkline Beecham Corp |
Method for administering a phosphodiesterase 4 inhibitor
|
US6348602B1
(en)
|
1999-12-23 |
2002-02-19 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6258833B1
(en)
|
1999-12-23 |
2001-07-10 |
Icos Corporation |
Cyclic AMP-specific phosphodiesterase inhibitors
|
US6379682B1
(en)
|
2000-02-07 |
2002-04-30 |
Color Access, Inc. |
Clear water-in-oil emulsions
|
US20030207845A1
(en)
|
2001-02-08 |
2003-11-06 |
Keating Elizabeth T. |
Method and compositions for treating an inflammatory disease
|
JP2004500404A
(ja)
|
2000-03-27 |
2004-01-08 |
カール − ツァイス − シュティフツング |
生物活性ガラスを含む新規化粧品、ボディケア、洗浄剤および栄養サプリメント組成物および製造方法およびその使用
|
EP1289961A1
(de)
|
2000-05-25 |
2003-03-12 |
Merck Frosst Canada & Co. |
Fluoroalkoxy-substituiertes benzamid-dichloropyridinyl-n-oxid als pde4 inhibitor
|
EP1161950A1
(de)
|
2000-06-09 |
2001-12-12 |
Warner-Lambert Company |
Verwendung von Diazepinoindolen zur Behandlung von chronisch obstruktiver Lungenkrankheiten
|
AR029984A1
(es)
|
2000-07-27 |
2003-07-23 |
Smithkline Beecham Corp |
Metodo para reducir las exacerbaciones asociadas copd ambito
|
US20040005995A1
(en)
|
2001-07-26 |
2004-01-08 |
Edelson Jeffrey D |
Method for reducing exacerbations associated with copd
|
EP1199074A1
(de)
|
2000-09-15 |
2002-04-24 |
Warner-Lambert Company |
Pharmazeutische Zusammensetzungen zur Vorbeugung oder Behandlung von mit IL-12 Überproduktion assozierten Erkrankungen
|
US20020193393A1
(en)
|
2001-03-07 |
2002-12-19 |
Michel Pairet |
Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
|
US20100310477A1
(en)
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
CN100536844C
(zh)
|
2000-12-07 |
2009-09-09 |
尼科梅德有限责任公司 |
包含酸不稳定活性成分的糊剂形式的药物制剂
|
CN100528232C
(zh)
|
2000-12-07 |
2009-08-19 |
尼科梅德有限责任公司 |
包含酸不稳定活性成分的混悬液形式的药物制剂
|
UA80393C2
(uk)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
DE10061137B4
(de)
|
2000-12-07 |
2016-10-06 |
Takeda Gmbh |
Neue pharmazeutische Zubereitung
|
CA2430829C
(en)
|
2000-12-07 |
2010-06-22 |
Altana Pharma Ag |
Rapidly disintegrating tablet comprising an acid-labile active ingredient
|
AU2002230217B2
(en)
|
2001-02-15 |
2005-02-17 |
Tanabe Seiyaku Co., Ltd. |
Tablets quickly disintegrated in oral cavity
|
WO2002069939A2
(en)
|
2001-03-05 |
2002-09-12 |
Ortho-Mcneil Pharmaceutical, Inc. |
Taste masked pharmaceutical compositions
|
FR2821745B1
(fr)
|
2001-03-09 |
2004-07-02 |
Ethypharm Lab Prod Ethiques |
Granules et granules enrobes au gout masque
|
US6702796B2
(en)
|
2001-03-26 |
2004-03-09 |
The Procter & Gamble Company |
Absorbent interlabial device having an improved tab
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
US6872382B1
(en)
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
US20030092706A1
(en)
|
2001-11-09 |
2003-05-15 |
Johannes Barsig |
Combination
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
US6756392B2
(en)
|
2002-02-11 |
2004-06-29 |
Pfizer Inc |
Nicotinamide derivatives useful as PDE4 inhibitors
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
NZ537308A
(en)
|
2002-05-28 |
2009-09-25 |
Nycomed Gmbh |
Ophthalmological use of roflumilast for the treatment of diseases of the eye
|
US20040058950A1
(en)
|
2002-07-09 |
2004-03-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
|
CN102755646A
(zh)
|
2002-07-19 |
2012-10-31 |
艾博特生物技术有限公司 |
TNF α相关疾病的治疗
|
US20030018071A1
(en)
|
2002-08-09 |
2003-01-23 |
Rennard Stephen I. |
Method and compositions for treating fibrotic diseases
|
ATE360627T1
(de)
|
2002-08-10 |
2007-05-15 |
Altana Pharma Ag |
Pyrrolidindion-substituierte piperidin- phthalazone als pde4-inhibitoren
|
US7329676B2
(en)
|
2002-08-29 |
2008-02-12 |
Nycomed Gmbh |
2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
|
CN1688292A
(zh)
|
2002-09-04 |
2005-10-26 |
兰贝克赛实验室有限公司 |
掩味剂型及其制造方法
|
US6822114B1
(en)
|
2002-10-08 |
2004-11-23 |
Albemarle Corporation |
Process for production of fluoroalkoxy-substituted benzamides and their intermediates
|
JP2006508993A
(ja)
|
2002-11-27 |
2006-03-16 |
アルタナ ファルマ アクチエンゲゼルシャフト |
ロフルミラスト及び(r,r)−ホルモテロールを含有する新規の相乗組合せ
|
PT1567139E
(pt)
|
2002-11-27 |
2008-10-01 |
Nycomed Gmbh |
Nova combinação sinérgica compreendendo roflumilaste e formoterol
|
WO2004052345A1
(en)
|
2002-12-11 |
2004-06-24 |
Ranbaxy Laboratories Limited |
Coating composition for taste masking coating and methods for their application and use
|
DE602004023478D1
(de)
|
2003-01-30 |
2009-11-19 |
Ethypharm Sa |
Geschmacksmaskierte beschichtete teilchen, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die beschichteten teilchen
|
RS52908B
(en)
|
2003-03-10 |
2014-02-28 |
Takeda Gmbh |
NEW PROCEDURE FOR OBTAINING ROFLUMILAST
|
WO2004084896A1
(en)
|
2003-03-28 |
2004-10-07 |
Altana Pharma Ag |
Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
|
MXPA05012302A
(es)
|
2003-05-22 |
2006-01-30 |
Altana Pharma Ag |
Composicion que comprende un inhibidor de pde4 y un inhibidor de pde5.
|
US20050026883A1
(en)
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
US20060228410A1
(en)
|
2003-08-11 |
2006-10-12 |
Hubert Dumont |
Flavored taste-masked pharmaceutical formulation made using a one-step coating process
|
WO2005020961A1
(en)
|
2003-08-28 |
2005-03-10 |
Sandoz Ag |
Pharmaceutical composition comprising anticonvulsant with taste mask coating
|
WO2005026095A1
(en)
|
2003-09-12 |
2005-03-24 |
Ranbaxy Laboratories Limited |
Process for the preparation of roflumilast
|
AU2004279438A1
(en)
|
2003-10-09 |
2005-04-21 |
Inverseon, Inc. |
Methods for treating diseases and conditions with inverse agonists
|
JP2007509154A
(ja)
|
2003-10-21 |
2007-04-12 |
ファルマシア・コーポレーション |
ホスホジエステラーゼ4阻害剤と組み合わせたシクロオキシゲナーゼ−2阻害剤による呼吸器炎症のの治療または予防のための方法およびその組成物
|
JP2007536350A
(ja)
|
2004-05-10 |
2007-12-13 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
肺気腫の予防又は治療のためのロフルミラストの使用
|
MX2007001585A
(es)
|
2004-08-12 |
2009-02-12 |
Sicor Inc |
Proceso para la preparacion de 3-oximino esteroides.
|
US20060105038A1
(en)
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
WO2006094640A2
(en)
|
2005-03-04 |
2006-09-14 |
F.Hoffmann-La Roche Ag |
Roflumilast and integrin inhibitor combination and method of treatment
|
EP1861074B1
(de)
|
2005-03-16 |
2013-04-24 |
Takeda GmbH |
Geschmacksmaskierte dosierform von roflumilast
|
US7745646B2
(en)
|
2006-07-07 |
2010-06-29 |
Kalypsys, Inc. |
Bicyclic heteroaryl inhibitors of PDE4
|
USD580547S1
(en)
|
2007-07-31 |
2008-11-11 |
Nycomed Gmbh |
Tablet
|
JP2009167052A
(ja)
|
2008-01-16 |
2009-07-30 |
Kyocera Corp |
単結晶シリコン粒子の製造方法
|
JP5271070B2
(ja)
|
2008-12-24 |
2013-08-21 |
エスアイアイ・プリンテック株式会社 |
ヘッドチップ、液体噴射ヘッド及び液体噴射装置
|